Levamlodipine placebo

DRUG2 trials

Sponsors

EMS, CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Conditions

Arterial HypertensionMild-to-moderate Essential Hypertension

Phase 3

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

WithdrawnNCT03814109

EMSArterial Hypertension

Start: 2022-04-30End: 2024-01-31Updated: 2022-07-27

A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients

Not yet recruitingNCT06771245

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Mild-to-moderate Essential Hypertension

Start: 2025-01-24End: 2026-10-30Target: 606Updated: 2025-01-13